Information | |
---|---|
has gloss | eng: Azor is the brand name of an oral antihypertensive medication which combines two antihypertensive agents in a film-coated tablet. It contains amlodipine, a calcium channel blocker, and olmesartan medoxomil, an angiotensin-2 receptor antagonist (ARB or A2A). The patent is held by Daiichi Sankyo Pharmaceuticals. Daiichi Sankyo filed a supplemental New Drug Application (sNDA) for Azor with the United States Food and Drug Administration on September 17, 2008. Azor has been studied in clinical trials; one test showed it reduced blood pressure during a 24-hour period and was well tolerated. Azor is available in different dose preparations: 5mg/20mg, 10mg/20mg,5mg/40mg and 10/40mg's of amlodipine and olmesartan respectively. |
lexicalization | eng: Azor |
instance of | e/Antihypertensive |
Lexvo © 2008-2025 Gerard de Melo. Contact Legal Information / Imprint